Prof. Lin Shen

✓ Available through China Expert Care

Director, Department of Gastrointestinal Oncology, and Director, Phase I Clinical Trial Ward; Professor and Chief Physician
Department of Gastrointestinal Oncology, Peking University Cancer Hospital

Prof. Lin Shen

Focus: Drug treatment of stomach and other gastrointestinal cancers, including immunotherapy and CLDN18.2 CAR-T therapy

Prof. Shen leads the Department of Gastrointestinal Oncology at Peking University Cancer Hospital. Senior author of the pivotal randomised trial of satri-cel, the first randomised CAR-T trial in a solid tumour, on which its 2026 approval in China was based, and first author of the phase III trial of cadonilimab plus chemotherapy as first-line treatment for advanced stomach cancer.

Conditions: Stomach cancer, CAR-T cell therapy

Selected publications

Profile on the hospital website: https://www.bjcancer.org/Html/Doctors/Main/Index_31049.html

Request a written opinion from Prof. Lin Shen

Send your records. A medical coordinator will reply within 24 hours.

Start here